AMGEN Long Term Debt

AMGEN (AMGN) currently reports a long-term debt of $52B as of March 2026. That compares with $54B in the prior-year period — down 3.9% year over year. Use the charts on this page to explore AMGEN's long-term debt history and peer comparisons.

AMGEN's long-term debt decreased from $54B to $52B — a 3.9% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AMGEN reported $52B in long-term debt as of March 2026. That compares with $54B in the prior-year period — down 3.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $52B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AMGEN, and consider following AMGN for alerts when major investors trade the stock.

AMGEN is classified in the Healthcare sector. On long-term debt, it currently shows $52B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AMGN with unrelated industries.